Edition:
United States

AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

11.72USD
16 Feb 2018
Change (% chg)

$0.32 (+2.81%)
Prev Close
$11.40
Open
$11.36
Day's High
$11.97
Day's Low
$11.23
Volume
28,782
Avg. Vol
25,948
52-wk High
$13.91
52-wk Low
$6.24

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.07 -0.154
Jun '17 0.75 -0.216
Mar '17 2.01 -0.166
FY 2016 Dec '16 1.43 -0.124
Sep '16 1.33 -0.169
Jun '16 19.96 0.240
Mar '16 0.49 -0.114
 
*Note: Units in Millions ofSwiss Francs
**Note: Units in Swiss Francs

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 7.08 7.08 7.08 --
Quarter Ending Jun-18 1 7.68 7.68 7.68 --
Year Ending Dec-18 3 25.08 25.27 24.87 7.18
Earnings (per share)
Quarter Ending Mar-18 1 -0.10 -0.10 -0.10 --
Quarter Ending Jun-18 1 -0.11 -0.11 -0.11 --
Year Ending Dec-18 3 -0.71 -0.58 -0.85 -1.11
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.11 34.43
P/E High - Last 5 Yrs. -- 280.23 46.75
P/E Low - Last 5 Yrs. -- 91.71 24.14
Beta -- 0.82 0.81
Price to Sales (TTM) 117.27 140.57 8.57
Price to Book (MRQ) 5.48 18.76 5.14
Price to Tangible Book (MRQ) 5.48 25.38 6.30
Price to Cash Flow (TTM) -- 118.58 25.75
% Owned Institutions 21.33 12.07 2.33

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.27
Payout Ratio(TTM) -- 9.21 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -19.43 43.07 9.45
Sales (TTM) vs TTM 1 Yr. Ago -76.18 45.64 7.30
Sales - 5 Yr. Growth Rate -- 32.43 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 8.84 0.41 20.15
EPS (TTM) vs TTM 1 Yr. Ago -413.76 -- --
EPS - 5 Yr. Growth Rate -- 44.88 11.48
Capital Spending - 5 Yr. Growth Rate -- 41.98 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.78 2.42
Current Ratio (MRQ) 14.93 6.17 3.38
LT Debt to Equity (MRQ) 0.35 16.64 11.85
Total Debt to Equity (MRQ) 0.35 18.80 15.12
Interest Coverage (TTM) -30.78 -165.32 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 50.23 54.90
Gross Margin - 5 Yr. Avg. -- 55.34 52.64
EBITD Margin (TTM) -651.89 -- --
EBITD - 5 Yr. Avg -- -567.40 9.86
Operating Margin (TTM) -661.01 -697.09 1.25
Operating Margin - 5 Yr. Avg. -- -588.12 5.07
Pre-Tax Margin (TTM) -671.52 -664.73 2.12
Pre-Tax Margin - 5 Yr. Avg. -- -596.31 5.33
Net Profit Margin (TTM) -671.52 -659.23 -1.38
Net Profit Margin - 5 Yr. Avg. -- -600.20 1.62
Effective Tax Rate (TTM) -- 1.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 18.11 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 84,683 23,305,201 819,569,446
Net Income/Employee (TTM) -568,664 -626,600 95,804,981
Receivable Turnover (TTM) 8.66 15.04 5.40
Inventory Turnover (TTM) -- 2.52 3.48
Asset Turnover (TTM) 0.04 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -24.70 -1.27 10.68
Return on Assets - 5 Yr. Avg. -- -0.48 12.00
Return on Investment (TTM) -26.48 -1.15 13.54
Return on Investment - 5 Yr. Avg. -- 2.13 15.72
Return on Equity (TTM) -27.30 -20.84 14.80
Return on Equity - 5 Yr. Avg. -- -2.48 16.91
  1 Year 3 Year 5 Year
Sales % -40.61 39.04 --
EPS (TTM) % -137.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AC Immune SA

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 21.33%
# of Holders: 28
Total Shares Held: 12,111,344
3 Mo. Net Change: 1,779,291
# New Positions: 9
# Closed Positions: 0
# Increased Positions: 14
# Reduced Positions: 3
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.